Alexandra Iouranova

Program lead @HAYA_lncRNA. Formerly @Trono_Lab @epflSV. Gene regulation enthusiast. @[email protected]

[HAYA Therapeutics @HAYA_lncRNA]

Happy #TransposonDay!
#TransposableElements—discovered by Nobel Prize winner #BarbaraMcClintock—were once considered mere part of the "junk DNA" but are now known to drive #EvolutionaryInnovation.

[HAYA Therapeutics @HAYA_lncRNA]

Join HAYA’s CEO, @ispiyou, for the #Longevity panel session at #BIO2026!

Discover how #HAYA leverages the #RegulatoryGenome to advance precision #CellularReprogramming to address chronic and age-related diseases.🧬

➡️ Learn more: https://t.co/DpXiMOa0dE

See you in San Diego!

[HAYA Therapeutics @HAYA_lncRNA]

🚀#HAYATherapeutics has been recognized by #IDEAPharma as a #DisruptivePioneer!

This is a validation of our core mission: to advance investigational, precision #RNAguidedTherapies with the potential to tackle the actual root drivers of common and #ChronicDiseases.

[HAYA Therapeutics @HAYA_lncRNA]

➡️https://t.co/jhOclG3Cwz

A huge thank you to our team and everyone who helped us reach this important #milestone!

[HAYA Therapeutics @HAYA_lncRNA]

#HAYA is officially a #Clinical-stage company!

The first cohort has been dosed in our #Phase1 clinical trial evaluating #HTX001, a first-in-class investigational therapy targeting the #lncRNA #WISPER for #nHCM. 🫀

[HAYA Therapeutics @HAYA_lncRNA]

#HAYA is heading to the #RIS2026!

Connect with our #CBO, @drrichjlaw to learn about our #Pulmonary programs focused on advancing #FirstInClass solutions for the #Treatment of #IPF by leveraging #noncodingRNAs.🫁🧬

If you attending, let’s connect!🤝

[Rich Law @drrichjlaw]

I'm looking forward to seeing folks in sunny Orlando. 😎

I'm really excited to discuss Haya's development candidate & atlas of novel biology; decoding & enabling lung remodelling & rejuvenation by targeting the regulatory genome. 🫁🧬 #RIS2026

[HAYA Therapeutics @HAYA_lncRNA]

#HAYATherapeutics will attend #TIDESUSA2026!

SVP Development, Denis Drygin, will showcase the #preclinical advancements for our lead #ASO candidate #HTX001.

Join us to discover how we leverage #RegulatoryGenome insights to design precision, programmable #RNAtherapeutics.

[Igor Ulitsky @IgorUlitsky]

🆕 review with @jp_unfried out in @NatureSMB 🧐. Direct roles of lncRNAs in transcriptional activation. What do we understand about how lncRNAs lure Pol2 and set the stage for RNA production, and what do we still miss? https://t.co/iYJQ7Rbb9d

[Alexis Ohanian 🗽 @alexisohanian]

@shae_mcl OK how do I fund decoding all of the non-coding genome!

[HAYA Therapeutics @HAYA_lncRNA]

Attending #cshlregRNA next week? 🇺🇸

#HAYA’s Senior Director of Biology and Functional Genomics, Rudi Micheletti, will present our lead program, with an emphasis on the #MoA and precision #ASO targeting of #WISPER, the master lncRNA driving #MyocardialFibrosis.

Let’s connect! 🤝

[EPFL Life Sciences @epflSV]

How cancer exploits a primate protein to control DNA stress https://t.co/N69ZSG9JK8 #epfl

[HAYA Therapeutics @HAYA_lncRNA]

🚀 We're thrilled to announce that #HAYATherapeutics have successfully raised $65Million in #SeriesA round of financing 🎉

A huge #THANKYOU to our TEAM, PARTNERS, and INVESTORS! 🙌
➡️https://t.co/lsRTHv8PbR

@SofinnovaVC @EarlybirdVC

[Wayo Matsushima @wayomayo]

New preprint of my postdoc work! We found a novel group of zinc-finger proteins that rapidly evolved in a lineage-specific manner to repress regulatory activities of transposon-derived sequences through anchoring nucleosomes.
https://t.co/vwI8BdMrQ9

[The Nobel Prize @NobelPrize]

BREAKING NEWS
The 2024 #NobelPrize in Physiology or Medicine has been awarded to Victor Ambros and Gary Ruvkun for the discovery of microRNA and its role in post-transcriptional gene regulation.

[24 heures @24heuresch]

Biologie moléculaire: Un accord à 1 milliard entre une start-up vaudoise et un géant de la pharma https://t.co/XogIfL3szP

[HAYA Therapeutics @HAYA_lncRNA]

🚀 We are thrilled to announce a multi-year #collaboration with @EliLillyandCo to discover novel #RegulatoryGenome targets for #Obesity & related #MetabolicConditions.

Learn more: https://t.co/oYYXlKS1IX

[Xiaoyu Zhuo @XiaoyuZhuo]

Our paper about TE's regulatory functions using ENCODE data has been published! https://t.co/9ngI3POHrc @twang5 @CedricFeschotte We confirmed TEs contributed 25% of regulatory elements in the human genome. We also investigated how different TEs contributed differently. /1

[Cedric🧬➰🧬Feschotte @CedricFeschotte]

💥Our new preprint!

Transposon ADDICTION in development!

Gag proteins of endogenous retroviruses are required for zebrafish development

Study led heroically by @sylviaandbu & @JN_Wells

This work has transformed my view of transposons, no less! 🧵1/n
https://t.co/d1yNgFbBSb

[Michael Imbeault @MichaelImbeault]

Our collaborative work on a primate-specific gene being essential for pancreas development in humans is out! https://t.co/YPrQCynyk1